Update on Gene Therapy Clinical Trials for Choroideremia and Potential Experimental Therapies
<i>Background and objectives</i>: Choroideremia (CHM) is an X-linked recessive chorioretinal dystrophy caused by mutations involving the <i>CHM</i> gene. Gene therapy has entered late-phase clinical trials, although there have been variable results. This review gives a summary on the outcomes of pha...
Shranjeno v:
| Principais autores: | , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI AG
2021-01-01
|
| Serija: | Medicina |
| Teme: | |
| Online dostop: | https://www.mdpi.com/1648-9144/57/1/64 |
| Oznake: |
Brez oznak, prvi označite!
|